MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,555,000 | +39.6% | 9,998,000 | 0.0% | 0.10% | +21.8% |
| Q2 2017 | $6,128,000 | -26.3% | 9,998,000 | 0.0% | 0.08% | -39.5% |
| Q1 2017 | $8,319,000 | -30.8% | 9,998,000 | -21.3% | 0.13% | -16.8% |
| Q4 2016 | $12,027,000 | -23.7% | 12,698,000 | +0.1% | 0.16% | -34.0% |
| Q3 2016 | $15,765,000 | +12.7% | 12,688,000 | 0.0% | 0.24% | +10.8% |
| Q2 2016 | $13,985,000 | -26.9% | 12,688,000 | +0.0% | 0.21% | -61.0% |
| Q1 2016 | $19,141,000 | +2.7% | 12,687,000 | +0.7% | 0.54% | +35.7% |
| Q4 2015 | $18,633,000 | -4.8% | 12,600,000 | 0.0% | 0.40% | -13.2% |
| Q3 2015 | $19,576,000 | -25.9% | 12,600,000 | 0.0% | 0.46% | -23.0% |
| Q2 2015 | $26,434,000 | +4.6% | 12,600,000 | 0.0% | 0.60% | +19.0% |
| Q1 2015 | $25,282,000 | +5.3% | 12,600,000 | 0.0% | 0.50% | +7.9% |
| Q4 2014 | $23,999,000 | +22.2% | 12,600,000 | 0.0% | 0.47% | +13.9% |
| Q3 2014 | $19,643,000 | +17.1% | 12,600,000 | 0.0% | 0.41% | +11.7% |
| Q2 2014 | $16,768,000 | +33.2% | 12,600,000 | +1.6% | 0.37% | +35.9% |
| Q1 2014 | $12,592,000 | -4.1% | 12,400,000 | -0.8% | 0.27% | +3.8% |
| Q4 2013 | $13,125,000 | +27.1% | 12,500,000 | +8.7% | 0.26% | +13.0% |
| Q3 2013 | $10,327,000 | – | 11,500,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|